Patents by Inventor John Dumas

John Dumas has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210085870
    Abstract: In example methods and systems described, insulin therapy for a patient can be determined. At least one of a short-acting subcutaneous insulin dosage recommendation, a correction subcutaneous insulin dosage recommendation, an intravenous insulin dosage recommendation, a recommended amount of carbohydrates to be administered to the patient, or combinations thereof, can be determined. In addition, information indicating a confirmation of a nutrition intake for the patient, and a long-acting insulin-on-board for the patient can be received, and based on this information, a required long-acting subcutaneous or intravenous insulin dosage for the patient can be determined. The short-acting subcutaneous or intravenous insulin dosage recommendation can be adjusted based, at least in part, on a difference between the long-acting insulin-on-board and the required long-acting subcutaneous or intravenous insulin dosage.
    Type: Application
    Filed: November 20, 2020
    Publication date: March 25, 2021
    Applicant: MONARCH MEDICAL TECHNOLOGIES, LLC
    Inventors: TIMOTHY L. RUCHTI, WILLIAM PATRICK BURGESS, JOHN DUMAS, III, RONALD LISIECKI, CAROL DIAN MARTIN, LAURA SANTANA, JOHN HARRISON THORNLEY, JOANNE MARIE WATT
  • Patent number: 10842935
    Abstract: In example methods and systems described, insulin therapy for a patient can be determined. At least one of a short-acting subcutaneous insulin dosage recommendation, a correction subcutaneous insulin dosage recommendation, an intravenous insulin dosage recommendation, a recommended amount of carbohydrates to be administered to the patient, or combinations thereof, can be determined. In addition, information indicating a confirmation of a nutrition intake for the patient, and a long-acting insulin-on-board for the patient can be received, and based on this information, a required long-acting subcutaneous or intravenous insulin dosage for the patient can be determined. The short-acting subcutaneous or intravenous insulin dosage recommendation can be adjusted based, at least in part, on a difference between the long-acting insulin-on-board and the required long-acting subcutaneous or intravenous insulin dosage.
    Type: Grant
    Filed: July 30, 2018
    Date of Patent: November 24, 2020
    Assignee: Monarch Medical Technologies, LLC
    Inventors: Timothy L. Ruchti, William Patrick Burgess, John Dumas, III, Ronald Lisiecki, Carol Dian Martin, Laura Santana, John Harrison Thornley, Joanne Marie Watt
  • Publication number: 20180333535
    Abstract: In example methods and systems described, insulin therapy for a patient can be determined. At least one of a short-acting subcutaneous insulin dosage recommendation, a correction subcutaneous insulin dosage recommendation, an intravenous insulin dosage recommendation, a recommended amount of carbohydrates to be administered to the patient, or combinations thereof, can be determined. In addition, information indicating a confirmation of a nutrition intake for the patient, and a long-acting insulin-on-board for the patient can be received, and based on this information, a required long-acting subcutaneous or intravenous insulin dosage for the patient can be determined. The short-acting subcutaneous or intravenous insulin dosage recommendation can be adjusted based, at least in part, on a difference between the long-acting insulin-on-board and the required long-acting subcutaneous or intravenous insulin dosage.
    Type: Application
    Filed: July 30, 2018
    Publication date: November 22, 2018
    Applicant: Monarch Medical Technologies, LLC
    Inventors: Timothy L. Ruchti, William Patrick Burgess, John Dumas, III, Ronald Lisiecki, Carol Dian Martin, Laura Santana, John Harrison Thornley, Joanne Marie Watt
  • Patent number: 10046781
    Abstract: A wheelbarrow for carrying materials is described herein, and may include a main frame having first and second spaced-apart elongate longitudinal arms and a support structure configured to engage the ground when the wheelbarrow is in a stationary position, a load carrying container for receiving a load therein, the load carrying container being mounted to and supported by the main frame and configured for supporting a load, an axle mounted to the main frame and below the container, and a ground engaging wheel rotatably mounted on the axle for moving the wheelbarrow in a mobile position. A hollow interior of the load carrying container may have an upper region and a lower region, the upper region located above the ground engaging wheel and extending along a substantial portion of a width of the container.
    Type: Grant
    Filed: May 21, 2015
    Date of Patent: August 14, 2018
    Assignee: ERGO MATE PTY LTD
    Inventors: Philip John Dumas, Benjamin Mark Green
  • Patent number: 10046113
    Abstract: In example methods and systems described, insulin therapy for a patient can be determined. At least one of a short-acting subcutaneous insulin dosage recommendation, a correction subcutaneous insulin dosage recommendation, an intravenous insulin dosage recommendation, a recommended amount of carbohydrates to be administered to the patient, or combinations thereof, can be determined. In addition, information indicating a confirmation of a nutrition intake for the patient, and a long-acting insulin-on-board for the patient can be received, and based on this information, a required long-acting subcutaneous or intravenous insulin dosage for the patient can be determined. The short-acting subcutaneous or intravenous insulin dosage recommendation can be adjusted based, at least in part, on a difference between the long-acting insulin-on-board and the required long-acting subcutaneous or intravenous insulin dosage.
    Type: Grant
    Filed: December 21, 2012
    Date of Patent: August 14, 2018
    Assignee: Monarch Medical Technologies, LLC
    Inventors: Timothy L. Ruchti, William Patrick Burgess, John Dumas, III, Ronald Lisiecki, Carol Dian Martin, Laura Santana, John Harrison Thornley, Joanne Marie Watt
  • Publication number: 20170165425
    Abstract: In example methods and systems described, insulin therapy for a patient can be determined. At least one of a short-acting subcutaneous insulin dosage recommendation, a correction subcutaneous insulin dosage recommendation, an intravenous insulin dosage recommendation, a recommended amount of carbohydrates to be administered to the patient, or combinations thereof, can be determined. In addition, information indicating a confirmation of a nutrition intake for the patient, and a long-acting insulin-on-board for the patient can be received, and based on this information, a required long-acting subcutaneous or intravenous insulin dosage for the patient can be determined. The short-acting subcutaneous or intravenous insulin dosage recommendation can be adjusted based, at least in part, on a difference between the long-acting insulin-on-board and the required long-acting subcutaneous or intravenous insulin dosage.
    Type: Application
    Filed: December 21, 2012
    Publication date: June 15, 2017
    Applicant: EndoTool, LLC
    Inventors: Timothy L. Ruchti, William Patrick Burgess, John Dumas, III, Ronald Lisiecki, Carol Dian Martin, Laura Santana, John Harrison Thornley, Joanne Marie Watt
  • Publication number: 20150329131
    Abstract: A wheelbarrow for carrying materials is described herein, and may include a main frame having first and second spaced-apart elongate longitudinal arms and a support structure configured to engage the ground when the wheelbarrow is in a stationary position, a load carrying container for receiving a load therein, the load carrying container being mounted to and supported by the main frame and configured for supporting a load, an axle mounted to the main frame and below the container, and a ground engaging wheel rotatably mounted on the axle for moving the wheelbarrow in a mobile position. A hollow interior of the load carrying container may have an upper region and a lower region, the upper region located above the ground engaging wheel and extending along a substantial portion of a width of the container.
    Type: Application
    Filed: May 21, 2015
    Publication date: November 19, 2015
    Inventors: Philip John Dumas, Benjamin Mark Green
  • Publication number: 20070048785
    Abstract: Anti-IL-13 antibodies, crystals of anti-IL-13 antibodies, IL-13 polypeptide/anti-IL-13 antibody complexes, crystals of IL-13 polypeptide/anti-IL-13 antibody complexes, IL-13R?1 polypeptide/IL-13 polypeptide/anti-IL-13 antibody complexes, crystals of IL-13R?1 polypeptide/IL-13 polypeptide/anti-IL-13 antibody complexes, and related methods and software systems are disclosed.
    Type: Application
    Filed: June 9, 2005
    Publication date: March 1, 2007
    Inventors: Laura Lin, Kevin Parris, Amy Sze Tam, Xiang-Yang Tan, Tania Shane, John Dumas, James Wilhelm, Mark Stahl, Lidia Mosyak, Zhixiang Hu
  • Patent number: 6569925
    Abstract: The present invention is directed to a an accelerator-gel additive used to deliver an accelerator such as sulfur, into a system for the production of polymer modified asphalt, vulcanized rubber or similar system. Unlike conventional methods of delivering accelerator into the system, the accelerator-gel additive suspends the accelerator in a gel system thereby preventing the sedimentation of the accelerator during processing. As a result, the polymer and asphalt are processed at lower temperature reducing the production of toxic and flammable gases such as hydrogen sulfide.
    Type: Grant
    Filed: August 9, 2002
    Date of Patent: May 27, 2003
    Assignee: Ergon, Incorporated
    Inventors: Gaylon L. Baumgardner, Martin R. Burrow, John Dumas, Andrew Menapace, James Smith
  • Patent number: 6569351
    Abstract: The present invention is directed to a an accelerator-gel additive used to deliver an accelerator such as sulfur, into a system for the production of polymer modified asphalt, vulcanized rubber or similar system. Unlike conventional methods of delivering accelerator into the system, the accelerator-gel additive suspends the accelerator in a gel system thereby preventing the sedimentation of the accelerator during processing. As a result, the polymer and asphalt are processed at lower temperature reducing the production of toxic and flammable gases such as hydrogen sulfide.
    Type: Grant
    Filed: March 14, 2000
    Date of Patent: May 27, 2003
    Assignee: Ergon, Inc.
    Inventors: Gaylon L. Baumgardner, Martin R. Burrow, John Dumas, Andrew Menapace, James Smith
  • Publication number: 20030004234
    Abstract: The present invention is directed to a an accelerator-gel additive used to deliver an accelerator such as sulfur, into a system for the production of polymer modified asphalt, vulcanized rubber or similar system. Unlike conventional methods of delivering accelerator into the system, the accelerator-gel additive suspends the accelerator in a gel system thereby preventing the sedimentation of the accelerator during processing. As a result, the polymer and asphalt are processed at lower temperature reducing the production of toxic and flammable gases such as hydrogen sulfide.
    Type: Application
    Filed: August 9, 2002
    Publication date: January 2, 2003
    Inventors: Gaylon L. Baumgardner, Martin R. Burrow, John Dumas, Andrew Menapace, James Smith
  • Patent number: D811680
    Type: Grant
    Filed: March 23, 2015
    Date of Patent: February 27, 2018
    Assignee: ERGO MATE PTY LTD
    Inventors: Philip John Dumas, Benjamin Mark Green